Wafaa El-Sadr | |
---|---|
Born | August 1950 |
Education | Cairo University (MD), Columbia Mailman School of Public Health (MSc Epidemiology), John F. Kennedy School of Government - Harvard University (MSc Public Administration) |
Occupation(s) | Physician, Epidemiologist |
Employer | Columbia University |
Known for |
Wafaa El-Sadr is a Columbia University Professor and the director of ICAP at Columbia University, Columbia World Projects [1] and the Center for Infectious Disease Epidemiologic Research (CIDER) at Columbia Mailman School of Public Health. [2]
El-Sadr holds a medical degree from Cairo University, Egypt, a master's of public health degree in epidemiology from the Columbia Mailman School of Public Health, and a master's in public administration degree from the John F. Kennedy School of Government at Harvard University. She is Board certified in internal medicine and infectious diseases. [3]
From 1988 to 2008, El-Sadr led the Division of Infectious Diseases at Harlem Hospital Center, where she helped develop HIV/AIDS and tuberculosis (TB) program. [4] She has led a number of research studies and grant-funded programs through funding from the National Institutes of Health, U.S. Centers for Disease Control and Prevention, U.S. Agency for International Development, Health Resources and Services Administration, New York State and New York City Departments of Health as well as private foundations.[ citation needed ]
Working with former dean of the Columbia University Mailman School of Public Health Allan Rosenfield, El-Sadr helped establish the MTCT-Plus initiative, a global program that aims to provide women and their families with HIV-related services. ICAP covers 13 countries in sub-Saharan Africa.[ citation needed ] ICAP entered into a settlement with the US Department of Justice for fraud and submission of false claims in 2014, and paid $9 million in restitution to the US government.
In 2011, she has focused her efforts on highlighting the continued impact of HIV in the United States, establishing the Domestic Prevention Working Group within the NIH-funded HIV Prevention Trials Network. [5]
In 2008, El-Sadr was named a John D. and Catherine T. MacArthur Foundation Fellow. [2] In 2009, Rolling Stone magazine named El-Sadr in its list of "100 People Who Are Changing America." [6] In the same year, she was also named as one of Scientific American 10: Guiding Science for Humanity. [7] She is also a member of the Institute of Medicine of the National Academies. In November 2009, The Utne Reader named El-Sadr one of the "50 Visionaries Who Are Changing Your World." [8]
El-Sadr is a member of the science planning committees for the International AIDS Society conference in Vienna (2010) [9] and the Conference on Retroviruses and Opportunistic Infections (CROI, 2010). [10] She is currently a member of the Technical Advisory Group on Tuberculosis for the World Health Organization [11] and a board member for the Population Council. [12] She has served as a member of the Antiviral Advisory Committee for the U.S. Food and Drug Administration, [13] and the Advisory Council for the Elimination of TB at the U.S. Centers for Disease Control and Prevention. [14] She also has served on the amfAR board. [15] She is a fellow of the Infectious Diseases Society of America and previously chaired its tuberculosis committee. [16] In 2021, she became the director of Columbia World Projects at Columbia University.[ citation needed ]
The United States President's Emergency Plan For AIDS Relief (PEPFAR) is a United States governmental initiative to address the global HIV/AIDS epidemic and help save the lives of those suffering from the disease. Launched by U.S. President George W. Bush in 2003, as of May 2020, PEPFAR has provided about $90 billion in cumulative funding for HIV/AIDS treatment, prevention, and research since its inception, making it the largest global health program focused on a single disease in history until the COVID-19 pandemic. PEPFAR is implemented by a combination of U.S. government agencies in over 50 countries and overseen by the Global AIDS Coordinator at the United States Department of State. As of 2023, PEPFAR has saved over 25 million lives, primarily in sub-Saharan Africa.
Sir Roy Malcolm Anderson is a leading international authority on the epidemiology and control of infectious diseases. He is the author, with Robert May, of the most highly cited book in this field, entitled Infectious Diseases of Humans: Dynamics and Control. His early work was on the population ecology of infectious agents before focusing on the epidemiology and control of human infections. His published research includes studies of the major viral, bacterial and parasitic infections of humans, wildlife and livestock. This has included major studies on HIV, SARS, foot and mouth disease, bovine tuberculosis, bovine spongiform encephalopathy (BSE), influenza A, antibiotic resistant bacteria, the neglected tropical diseases and most recently COVID-19. Anderson is the author of over 650 peer-reviewed scientific articles with an h-index of 125.
Awa Marie Coll-Seck is a Senegalese infectious diseases specialist and politician who served as Minister of Health of Senegal from 2001 to 2003 and again from 2012 to 2017. She also served as former Executive Director of the Roll Back Malaria Partnership and is on the board of directors of several notable global health organizations. She is an agenda contributor of the World Economic Forum.
The Joseph L. Mailman School of Public Health is the public health graduate school of Columbia University. Located on the Columbia University Irving Medical Center campus in the Washington Heights neighborhood of Manhattan, New York City, the school is accredited by the Council on Education for Public Health.
Seth Franklin Berkley is an American medical epidemiologist and a global advocate of the power of vaccines. He is the founder and former president and CEO of the International AIDS Vaccine Initiative (IAVI) and former CEO of Gavi, the Vaccine Alliance. He is currently a senior advisor to the Pandemic Center at Brown University School of Public Health.
Margaret Ann "Peggy" Hamburg is an American physician and public health administrator, who is serving as the chair of the board of the American Association for the Advancement of Science (AAAS) and co-chair of the InterAcademy Partnership (IAP). She served as the 21st Commissioner of the U.S. Food and Drug Administration from May 2009 to April 2015.
ICAP at Columbia University's Mailman School of Public Health supports programs and research that address HIV/AIDS and related conditions and works to strengthen health systems. ICAP currently supports HIV/AIDS prevention, care and treatment programs in 19 African countries including: Angola, Cameroon, Côte d'Ivoire, Democratic Republic of Congo, Ethiopia, Kenya, Lesotho, Malawi, Mali, Mozambique, Namibia, Sierra Leone, South Africa, South Sudan, Swaziland, Tanzania, Uganda, Zambia, and Zimbabwe. It also works in Central Asia, Ukraine, Georgia, Myanmar, Brazil, Guatemala, China, Jordan, Lebanon, and Turkey. ICAP supports several hundred project sites, which provide HIV prevention, care and treatment to hundreds of thousands of individuals.
Agnes Binagwaho is a Rwandan Politician, pediatrician, co-founder and the former vice chancellor of the University of Global Health Equity (2017-2022). In 1996, she returned to Rwanda where she provided clinical care in the public sector as well as held many positions including the position of Permanent Secretary for the Ministry of Health of Rwanda from October 2008 until May 2011 and Minister of Health from May 2011 until July 2016. She has been a professor of global health delivery practice since 2016 and a professor of pediatrics since 2017 at the University of Global Health Equity. She has served the health sector in various high-level government positions. She resides in Kigali.
mChip is a portable blood test device which is capable of diagnosing an infection of HIV or Syphilis within 15 minutes and could be used effectively against HIV/AIDS in developing countries. The mChip costs about US$ 1 and the entire diagnostic kit costs about US$ 100. mChip was developed so that people in regions with poor health facilities can access portable diagnosis for HIV/AIDS rather than travelling long distances to go to clinics for diagnosis.
Safiatou Thiam is a Senegalese public health doctor, a specialist in HIV/AIDS and former Minister of Health and Disease Prevention in the government of Cheikh Hadjibou Soumaré.She later became Executive Secretary of CNLS National Council against AIDS
Mary Jane Rotheram-Borus is a licensed clinical psychologist and professor with the University of California, Los Angeles, Department of Psychiatry and Biobehavioral Sciences. Rotheram is the professor-in-residence in the Semel Institute for Neuroscience and Human Behavior. She is the Director of the Global Center for Children and Families at UCLA and the former director of the Center for HIV Identification, Prevention, and Treatment Services.
Quarraisha Abdool Karim is an infectious diseases epidemiologist and co-founder and Associate Scientific Director of CAPRISA. She is a Professor in Clinical Epidemiology, Columbia University, New York and Pro-Vice Chancellor for African Health, University of KwaZulu-Natal, South Africa.
Salim S. Abdool Karim, MBChB, MMed, MS(Epi), FFPHM, FFPath (Virol), DipData, PhD, DSc(hc), FRS is a South African public health physician, epidemiologist and virologist who has played a leading role in the AIDS and COVID-19 pandemic. His scientific contributions have impacted the landscape of HIV prevention and treatment, saving thousands of lives.
Barry R. Bloom is Joan L. and Julius H. Jacobson Professor of Public Health, Emeritus in the Department of Immunology and Infectious Diseases and Department of Global Health and Population in the Harvard T.H. Chan School of Public Health, where he served as dean of the faculty from 1998 through December 31, 2008.
Roy D. Mugerwa was a Ugandan physician, cardiologist and researcher. His contribution to the world of academics include being a Professor Emeritus at Makerere University College of Health Sciences in Kampala, cardiology in Uganda, researching HIV/AIDS and tuberculosis, and his efforts to find an effective HIV vaccine.
Alash'le Grace Abimiku is a Nigerian executive director of the International Research Centre of Excellence at the Institute of Human Virology Nigeria and a professor of virology at the University of Maryland School of Medicine who takes interest in the prevention and treatment of HIV.
Adaora Alise Adimora was an American doctor and academic. She was the Sarah Graham Kenan Distinguished Professor of Medicine and professor of epidemiology at the University of North Carolina School of Medicine. Her research centered on the transmission of HIV, as well as other sexually transmitted infections (STIs), among minority populations. Her work highlighted the importance of social determinants of HIV transmission and the need for structural interventions to reduce risk. In 2019, she became an elected member of the National Academy of Medicine in recognition of her contributions.
Sten H. Vermund is the Anna M.R. Lauder Professor of Public Health, and former Dean (2017-2022) of the Yale School of Public Health, and also serves as a Professor in Pediatrics at the Yale School of Medicine. He is a pediatrician and infectious disease epidemiologist focused on diseases of low and middle-income countries.
Kimberly Y. Smith is an American scientific executive and medical doctor serving as the head of research and development at ViiV Healthcare.
Susan Swindells is an AIDS researcher.
Population Council Trustee Wafaa El-Sadr has been awarded a $500,000 genius grant from the John D. and Catherine T. MacArthur Foundation.